Scholars Central

Research articlePublished 31 Dec 2019

Absence of correlation between DAS28-ESR, DAS28-CRP, SDAI, CDAI and ultrasound scoring in patients with rheumatoid arthritis in remission

Authors: Melanie Trabelsi, Marion Cugnet, Athan Baillet, Marine Clay, Stephanie Rouanet, Elise Contant, Muriel Piperno, Florence Merle-Vincent, Deborah Gensburger, Claire Vidon, Hubert Marotte, Beatrice Pallot-Prades, Delphine Denarie, Adamah Amouzougan, Anne Cherasse, Laurent Grimault, Clementine Fortunet, Marie Bossert, Xavier Guillot, Isabelle Brault, Benoit Auge, Elodie Constant, Philippe Gaudin & Paul Ornetti

International Journal of Clinical Rheumatology

Volume 14 · Issue 6 · Pages 246

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Objective: Several composite scores (28-joints Disease Activity Score (DAS28), Simplified/Clinical Disease Activity Index (SDAI/CDAI)) may be used as target of therapeutic strategies in rheumatoid arthritis (RA) management. Although ultrasound (US) is a useful imaging technique in RA management, there are no validated US remission criteria. We aimed at analyzing correlations between US and clinical scores in RA patients with clinical remission. Methods: This French multicenter cross-sectional study, in 11 Rheumatology departments, consecutively included patients from August 2015 to April 2016. Inclusions criteria were: RA diagnosis meeting ACREULAR 2010 criteria, <15 years of progression, DAS28-ESR<2.6 for at least 3 months, stable treatment for at least 6 months, including steroids if necessary. Correlations between US scores (Naredo12 B-mode, PD-mode, combined B+PD mode, PDUS scores) and clinical remission composite scores (DAS28-ESR (Erythrocyte Sedimentation Rate), DAS28-CRP (C Reactive Protein), SDAI, CDAI) were analyzed. Results: 225 patients were analyzed. Intra/inter-observer reliabilities were good to excellent. Correlations between clinical and US Naredo12 scores were weak to moderate, with correlation coefficients ranging from 0.086 [-0.05; 0.21] to 0.323 [0.20; 0.44]. Best correlations were observed between PD-mode and SDAI or CDAI. US Naredo12 PD-mode score of 0/36 predicts a SDAI remission with 78% sensitivity and 49% specificity (area under curve 0.65). No association was found between US Naredo12 scores and type of treatment, remission duration or disease duration. Conclusions: There is no strong correlation between US and clinical scores in remission RA patients in routine care. US input in the definition of RA remission remains uncertain.

Subjects

Rheumatology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in International Journal of Clinical Rheumatology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInternational Journal of Clinical Rheumatology
  • SubjectRheumatology
  • BylineArticles whose byline prints “Melanie Trabelsi”
  • BylineArticles whose byline prints “Marion Cugnet”
  • BylineArticles whose byline prints “Athan Baillet”
  • BylineArticles whose byline prints “Marine Clay”
  • BylineArticles whose byline prints “Stephanie Rouanet”
  • BylineArticles whose byline prints “Elise Contant”
  • BylineArticles whose byline prints “Muriel Piperno”
  • BylineArticles whose byline prints “Florence Merle-Vincent”